Summary - Funding Rounds

Founding Date

2018

Total Funding

$171.6 m

Investors

In total, Myriad Women’s Health had raised $171.6 m. Myriad Women’s Health is a subsidiary of Myriad Genetics

Myriad Women’s Health Revenue Breakdown

Embed Graph

Myriad Women’s Health revenue breakdown by business segment: 9.8% from Revenue from tests billed through out-of-network payers, 15.0% from Revenue from tests billed through laboratory service intermediaries, 74.4% from Revenue from tests billed through in-network payers and 0.8% from Other

Myriad Women’s Health Funding Rounds

DateShares IssuedShare PriceAmount RaisedPost-money ValuationValuation Step-up

Series A

Apr 20091,752,000$4.28$7.5 m$168 m

Series B

Mar 20107,138,000$5.05$36 m$234.8 m1.4

Series C

Aug 2012928,000$8.84$8.2 m$438.6 m1.9

Series D

May 20144,613,000$10.84$50 m$893.7 m2

Private Equity

Nov 2017$80 m

Myriad Women’s Health Income Statement

Annual

USDFY, 2017

Revenue

124.0m

Cost of goods sold

55.3m

Gross profit

68.7m

Gross profit Margin, %

55%

Sales and marketing expense

46.7m

R&D expense

23.3m

General and administrative expense

29.1m

Operating expense total

99.0m

EBIT

(30.3m)

EBIT margin, %

(24%)

Interest expense

6.0m

Net Income

(37.3m)

Quarterly

USDQ1, 2018

Revenue

102.6m

Cost of goods sold

44.8m

Gross profit

57.8m

Gross profit Margin, %

56%

R&D expense

17.4m

General and administrative expense

57.8m

Operating expense total

75.2m

EBIT

(17.4m)

EBIT margin, %

(17%)

Interest expense

6.8m

Net Income

(25.3m)

Myriad Women’s Health Balance Sheet

Annual

USDFY, 2017

Cash

34.0m

Accounts Receivable

16.2m

Prepaid Expenses

3.6m

Inventories

3.9m

Current Assets

57.7m

PP&E

14.1m

Total Assets

72.6m

Accounts Payable

4.2m

Short-term debt

1.1m

Current Liabilities

18.2m

Long-term debt

68.6m

Total Debt

69.7m

Total Liabilities

103.5m

Common Stock

18.0k

Preferred Stock

90.5m

Additional Paid-in Capital

28.5m

Retained Earnings

(149.9m)

Total Equity

(121.4m)

Debt to Equity Ratio

-0.6 x

Debt to Assets Ratio

1 x

Financial Leverage

-0.6 x

Quarterly

USDQ1, 2018

Cash

23.7m

Accounts Receivable

21.7m

Inventories

3.8m

Current Assets

53.8m

PP&E

13.1m

Total Assets

70.0m

Accounts Payable

3.2m

Current Liabilities

18.4m

Long-term debt

67.8m

Total Debt

67.8m

Total Liabilities

105.1m

Common Stock

18.0k

Additional Paid-in Capital

28.6m

Retained Earnings

(154.2m)

Total Equity

(125.6m)

Debt to Equity Ratio

-0.5 x

Debt to Assets Ratio

1 x

Financial Leverage

-0.6 x

Myriad Women’s Health Cash Flow

Annual

USDFY, 2017

Net Income

(37.3m)

Depreciation and Amortization

7.7m

Accounts Receivable

(2.1m)

Inventories

(801.0k)

Accounts Payable

2.3m

Cash From Operating Activities

(25.0m)

Purchases of PP&E

(5.7m)

Cash From Investing Activities

(5.7m)

Short-term Borrowings

(813.0k)

Long-term Borrowings

(45.0m)

Cash From Financing Activities

33.0m

Net Change in Cash

2.4m

Interest Paid

4.8m

Myriad Women’s Health Ratios

USDFY, 2017

Revenue/Employee

257.6k

Debt/Equity

-0.6 x

Debt/Assets

1 x

Financial Leverage

-0.6 x

Myriad Women’s Health Operating Metrics

Mar, 2017Jan, 2018

Genetic Counseling Sessions

75 k

Healthcare Professionals Served

10 k17 k

People Screened to Date

750 k850 k

Myriad Women’s Health Employee Rating

3.8101 votes
Culture & Values
4.2
Work/Life Balance
4.1
Senior Management
3.6
Salary & Benefits
3.8
Career Opportunities
3.8
Source